BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'

Reuters

Nov 11, 2024

BUZZ-<a href="https://laohu8.com/S/TEM">Tempus AI</a> drops after Stifel cuts to 'hold' from 'buy'

** Genetics testing firm Tempus AI's shares TEM.O fall 8.2% to $67.75

** Stifel cuts to "hold" from "buy"; raises price target to $65 from $45

** Brokerage says the valuation of stock looks stretched, after company commentary suggested 2025 outlook for core business might be guided below Street expectations

** Brokerage says co's acquisition of Ambry Genetics will be positive to overall business

** But it expects TEM's revenue growth to slow, especially in the data segment; points to the slower growth profile of Ambry's hereditary cancer testing market

** Avg rating of brokerages is a "buy"; median PT is $52 - LSEG data

** As of last close, TEM has risen 84.3% since its June 14 debut on Nasdaq

(Reporting by Sukriti Gupta in Bengaluru)

((Sukriti.Gupta@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2482024738"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2482024738\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2482024738?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-11 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482024738","market":"us","top_or_hot":-1,"title":"BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> drops after Stifel cuts to 'hold' from 'buy'</title></head><body><p>** Genetics testing firm Tempus AI's shares <span>TEM.O</span> fall 8.2% to $67.75</p><p>** Stifel cuts to \"hold\" from \"buy\"; raises price target to $65 from $45</p><p>** Brokerage says the valuation of stock looks stretched, after company commentary suggested 2025 outlook for core business might be guided below Street expectations</p><p>** Brokerage says co's acquisition of Ambry Genetics will be positive to overall business</p><p>** But it expects TEM's revenue growth to slow, especially in the data segment; points to the slower growth profile of Ambry's hereditary cancer testing market</p><p>** Avg rating of brokerages is a \"buy\"; median PT is $52 - LSEG data</p><p>** As of last close, TEM has risen 84.3% since its <span>June 14 debut on Nasdaq</span> </p><p> (Reporting by Sukriti Gupta in Bengaluru)</p><p> ((Sukriti.Gupta@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-11 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> drops after Stifel cuts to 'hold' from 'buy'</title></head><body><p>** Genetics testing firm Tempus AI's shares <span>TEM.O</span> fall 8.2% to $67.75</p><p>** Stifel cuts to \"hold\" from \"buy\"; raises price target to $65 from $45</p><p>** Brokerage says the valuation of stock looks stretched, after company commentary suggested 2025 outlook for core business might be guided below Street expectations</p><p>** Brokerage says co's acquisition of Ambry Genetics will be positive to overall business</p><p>** But it expects TEM's revenue growth to slow, especially in the data segment; points to the slower growth profile of Ambry's hereditary cancer testing market</p><p>** Avg rating of brokerages is a \"buy\"; median PT is $52 - LSEG data</p><p>** As of last close, TEM has risen 84.3% since its <span>June 14 debut on Nasdaq</span> </p><p> (Reporting by Sukriti Gupta in Bengaluru)</p><p> ((Sukriti.Gupta@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4N3MI0YS:1","article_id":"2482024738","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482024738","pubTimestamp":1731336554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'** Genetics testing firm Tempus AI's shares TEM.O fall 8.2% to $67.75** Stifel cuts to \"hold\" from \"buy\"; raises price target to $65 from $45** Brokerage says the valuation of stock looks stretched, after company commentary suggested 2025 outlook for core business might be guided below Street expectations** Brokerage says co's acquisition of Ambry Genetics will be positive to overall business** But it expects TEM's revenue growth to slow, especially in the data segment; points to the slower growth profile of Ambry's hereditary cancer testing market** Avg rating of brokerages is a \"buy\"; median PT is $52 - LSEG data** As of last close, TEM has risen 84.3% since its June 14 debut on Nasdaq   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI","BK4121":"生命科学工具和服务"},"translate_title":"Stifel将BUZZ-Tempus AI从“买入”下调至“持有”后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":0.9},"content_text":"BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'** Genetics testing firm Tempus AI's shares TEM.O fall 8.2% to $67.75** Stifel cuts to \"hold\" from \"buy\"; raises price target to $65 from $45** Brokerage says the valuation of stock looks stretched, after company commentary suggested 2025 outlook for core business might be guided below Street expectations** Brokerage says co's acquisition of Ambry Genetics will be positive to overall business** But it expects TEM's revenue growth to slow, especially in the data segment; points to the slower growth profile of Ambry's hereditary cancer testing market** Avg rating of brokerages is a \"buy\"; median PT is $52 - LSEG data** As of last close, TEM has risen 84.3% since its June 14 debut on Nasdaq  (Reporting by Sukriti Gupta in Bengaluru) ((Sukriti.Gupta@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}